← All Sponsors
SPONSOR

Prasun Kumar Jalal

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Alcoholic Hepatitis

Prasun Kumar Jalal is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Alcoholic Hepatitis.

The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Prasun Kumar Jalal

How many clinical trials has Prasun Kumar Jalal sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Prasun Kumar Jalal, of which 1 are actively recruiting participants. These trials cover conditions including Alcoholic Hepatitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Prasun Kumar Jalal research focus on?
Prasun Kumar Jalal clinical trials span Alcoholic Hepatitis. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Prasun Kumar Jalal clinical trial?
To participate in a Prasun Kumar Jalal trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Prasun Kumar Jalal trials with current recruitment status updated daily.

Clinical Trials by Prasun Kumar Jalal

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology